The heterogeneity of antipsychotic response in the treatment of schizophrenia von Case, M., Stauffer, V. L., Ascher-Svanum, H., Conley, R., Kapur, S., Kane, J. M., Kollack-Walker, S., Jacob, J., Kinon, B. J.

Volltext

Efficacy of galcanezumab in patients with episodic migraine and a history of preventive treatment failure: results from two global randomized clinical trials von Ruff, D. D., Ford, J. H., Tockhorn‐Heidenreich, A., Stauffer, V. L., Govindan, S., Aurora, S. K., Terwindt, G. M., Goadsby, P. J.

Volltext

Response to ‘Do different treatment strategies of galcanezumab have similar effect on migraine?’ von Goadsby, P. J., Terwindt, G. M., Ruff, D. D., Ford, J. H., Tockhorn‐Heidenreich, A., Stauffer, V. L., Govindan, S., Aurora, S. K.

Volltext

Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia von Fijal, B A, Kinon, B J, Kapur, S, Stauffer, V L, Conley, R R, Jamal, H H, Kane, J M, Witte, M M, Houston, J P

Volltext

Dose response and atypical antipsychotics in schizophrenia von KINON, Bruce J, AHL, Jonna, STAUFFER, Virginia L, HILL, Angela L, BUCKLEY, Peter F

Volltext

Olanzapine Plasma Concentrations After Treatment With 10, 20, and 40 mg/d in Patients With Schizophrenia: An Analysis of Correlations With Efficacy, Weight Gain, and Prolactin Conc... von CITROME, Leslie, STAUFFER, Virginia L, LEI CHEN, KINON, Bruce J, KURTZ, Darcie L, JACOBSON, Jennie G, BERGSTROM, Richard F

Volltext

Cost-effectiveness of early responders versus early nonresponders to atypical antipsychotic therapy von Peng, Xiaomei, Ascher-Svanum, Haya, Faries, Douglas E, Stauffer, Virginia L, Kollack-Walker, Sara, Kinon, Bruce J, Kane, John M

Volltext

Predictive Value of Early Changes in Triglycerides and Weight for Longer-Term Changes in Metabolic Measures During Olanzapine, Ziprasidone or Aripiprazole Treatment for Schizophren... von HOFFMANN, Vicki P, CASE, Michael, STAUFFER, Virginia L, JACOBSON, Jennie G, CONLEY, Robert R

Volltext

Comparison between prefilled syringe and autoinjector devices on patient-reported experiences and pharmacokinetics in galcanezumab studies von Stauffer, Virginia L, Sides, Ryan, Lanteri-Minet, Michel, Kielbasa, William, Jin, Yan, Selzler, Katherine J, Tepper, Stewart J

Volltext

Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine von Ford, Janet H, Foster, Shonda A, Stauffer, Virginia L, Ruff, Dustin D, Aurora, Sheena K, Versijpt, Jan

Volltext

Early Onset of Antipsychotic Action in Schizophrenia: Evaluating the Possibility of Shorter Acute Efficacy Trials von KINON, Bruce J, LEI CHEN, STAUFFER, Virginia L, SNIADECKI, Jennifer, ASCHER-SVANUM, Haya, KOLLACK-WALKER, Sara, JACOB, Jayanthi, KAPUR, Shitij

Volltext

PND44 - Effects of Galcanezumab on Healthcare Resource Utilization and Acute Medication Use in Patients with Migraine: Results from Two Global Phase 3 Clinical Trials von Ford, JH, Foster, SA, Detke, HC, Stauffer, VL, Ruff, DD, Aurora, SK

Volltext

Effects of Galcanezumab on Healthcare Resource Utilization and Acute Medication Use in Patients with Migraine: Results from Two Global Phase 3 Clinical Trials von Ford, JH, Foster, SA, Detke, HC, Stauffer, VL, Ruff, DD, Aurora, SK

Volltext

An excitement subscale of the Positive and Negative Syndrome Scale von Lindenmayer, Jean-Pierre, Brown, Eileen, Baker, Robert W., Schuh, Leslie M., Shao, Lixin, Tohen, Mauricio, Ahmed, Saeeduddin, Stauffer, Virginia L.

Volltext

Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia von Chen, Lei, Ascher-Svanum, Haya, Lawson, Anthony, Stauffer, Virginia L, Nyhuis, Allen, Haynes, Virginia, Schuh, Kory, Kinon, Bruce J

Volltext

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia von Ascher-Svanum, Haya, Brnabic, Alan Jm, Lawson, Anthony H, Kinon, Bruce J, Stauffer, Virginia L, Feldman, Peter D, Kelin, Katarina

Volltext

Acute dysphoric mania: Treatment response to olanzapine versus placebo von BAKER, Robert W, TOHEN, Mauricio, FAWCETT, Jan, RISSER, Richard C, SCHUH, Leslie M, BROWN, Eileen, STAUFFER, Virginia L, LIXIN SHAO, TOLLEFSON, Gary D

Volltext

PMH2 EARLY RESPONSE PREDICTS SUBSEQUENT RESPONSE TO OLANZAPINE LONG-ACTING INJECTIONS IN THE TREATMENT OF SCHIZOPHRENIA von Ascher-Svanum, H, Zhao, F, Nyhuis, A, Lawson, AH, Stauffer, VL, Montgomery, W, Witte, M, Detke, H, McDonnell, DP

Volltext

PMH51 THE COST-EFFECTIVENESS OF EARLY RESPONDERS VERSUS EARLY NON-RESPONDERS TO ATYPICAL ANTIPSYCHOTIC THERAPY von Peng, X, Ascher-Svanum, H, Faries, D, Stauffer, VL, Kollack-Walker, S, Kinon, BJ, Kane, JM

Volltext

PMH9 PATIENTS' EARLY PERCEPTIONS OF MEDICATIONS' BENEFITS PREDICT SUBSEQUENT RESPONSE IN THE TREATMENT OF SCHIZOPHRENIA von Nyhuis, A, Ascher-Svanum, H, Faries, D, Stauffer, VL, Kollack-Walker, S, Kinon, BJ, Weiden, PJ

Volltext